Chenzhong Xu

716 citations
24 papers · 539 indexed · h-index 14
Topics
RNA regulation and disease (4 papers)RNA modifications and cancer (4 papers)Telomeres, Telomerase, and Senescence (4 papers)
Partner nations
ChinaFranceHong Kong

In The Last Decade

Chenzhong Xu

22 papers receiving 537 citations

Peers

Chenzhong Xu
Comparison fields: 5 of 84
  • Molecular Biology 339
  • Cancer Research 96
  • Oncology 81
  • Physiology 81
  • Nutrition and Dietetics 65
Replace Stephen Jun Fei Chong with:
Stephen Jun Fei Chong Singapore
Sofia Bellou Greece
Jie-Jie Zhang China
Bryan M. Gillard United States
Domenico Di Marzo Italy
Kathryn J. Huber-Keener United States
Vijayalekshmi Nair United States
Yunpeng Xie China
Carly M. Sayers United States
Steve L. Abrams United States
Chenzhong Xu relative to Stephen Jun Fei Chong Singapore Stephen Jun Fei Chong's profile →
Citations per field
00.5×4.6×
Stephen Jun Fei Chong · 1×
Citations per year

Countries citing papers authored by Chenzhong Xu

Since Specialization
Citations

This map shows the geographic impact of Chenzhong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenzhong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenzhong Xu more than expected).

Fields of papers citing papers by Chenzhong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenzhong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenzhong Xu. The network helps show where Chenzhong Xu may publish in the future.

Co-authorship network of co-authors of Chenzhong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenzhong Xu. A scholar is included among the top collaborators of Chenzhong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenzhong Xu. Chenzhong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 2
5 11
6 5
7 5
8 10
9 26
10 10
11 17
12 31
13 17
14 21
15 32
16 31
17 130
18 40
19 52
20 17

About Chenzhong Xu

Chenzhong Xu is a scholar working on Geriatrics and Gerontology, Molecular Biology and Cancer Research, having authored 24 papers that have together received 539 indexed citations. Recurring topics across this work include RNA regulation and disease (4 papers), RNA modifications and cancer (4 papers) and Telomeres, Telomerase, and Senescence (4 papers). The work is most often cited by research in Aging (15 citations), Geriatrics and Gerontology (30 citations) and Cancer Research (96 citations). Chenzhong Xu has collaborated with scholars based in China, France and Hong Kong. Frequent co-authors include Pa Wu, Hui Luo, Yan Yang, Jing Duan, Qian Jiang, Tanjun Tong, Guodong Li, Jun Chen, Yuanyuan Su and Kejian Shi. Their work appears in journals such as Nature Communications, Molecular Cell and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026